MMADHC
Basic information
Region (hg38): 2:149569637-149587778
Previous symbols: [ "C2orf25" ]
Links
Phenotypes
GenCC
Source:
- methylmalonic aciduria and homocystinuria type cblD (Definitive), mode of inheritance: AR
- methylmalonic aciduria and homocystinuria type cblD (Moderate), mode of inheritance: AR
- methylmalonic aciduria and homocystinuria type cblD (Strong), mode of inheritance: AR
- methylmalonic aciduria and homocystinuria type cblD (Supportive), mode of inheritance: AR
- inborn disorder of cobalamin metabolism and transport (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Methylmalonic aciduria and homocystinuria, cblD type | AR | Biochemical | While no treatment is completely effective, specific dietary (eg, high-calorie, low protein diet and avoidance of fasting, with measures taken to avoid/treat decompensation) and other medical measures (eg, cofactor therapy) may be beneficial to treat and prevent sequelae in the acute and chronic states | Biochemical; Hematologic; Neurologic; Ophthalmologic | 5524089; 2339678; 15292234; 18385497; 20301409; 20301503; 22156578 |
ClinVar
This is a list of variants' phenotypes submitted to
- Methylmalonic aciduria and homocystinuria type cblD (26 variants)
- not provided (2 variants)
- Vitamin B12-responsive methylmalonic acidemia, type cblDv2 (2 variants)
- Cobalamin C disease (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMADHC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 92 | 94 | ||||
missense | 47 | 54 | ||||
nonsense | 11 | 20 | ||||
start loss | 0 | |||||
frameshift | 16 | 26 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 14 | 14 | ||||
splice region | 7 | 28 | 1 | 36 | ||
non coding | 62 | 20 | 86 | |||
Total | 27 | 31 | 55 | 158 | 24 |
Highest pathogenic variant AF is 0.0000197
Variants in MMADHC
This is a list of pathogenic ClinVar variants found in the MMADHC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-149569707-A-G | Disorders of Intracellular Cobalamin Metabolism • Methylmalonic aciduria and homocystinuria type cblD | Uncertain significance (Jan 13, 2018) | ||
2-149569733-T-C | Methylmalonic aciduria and homocystinuria type cblD • Disorders of Intracellular Cobalamin Metabolism | Uncertain significance (Jan 13, 2018) | ||
2-149569810-T-C | Methylmalonic aciduria and homocystinuria type cblD • Disorders of Intracellular Cobalamin Metabolism | Benign (Jan 12, 2018) | ||
2-149569848-T-C | Methylmalonic aciduria and homocystinuria type cblD • Disorders of Intracellular Cobalamin Metabolism | Benign (Jun 29, 2018) | ||
2-149569885-A-G | Methylmalonic aciduria and homocystinuria type cblD • Disorders of Intracellular Cobalamin Metabolism | Benign (Jun 29, 2018) | ||
2-149569974-C-T | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Oct 19, 2023) | ||
2-149569980-T-C | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Jan 28, 2023) | ||
2-149569980-T-G | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Jul 02, 2021) | ||
2-149569988-A-G | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Jul 03, 2022) | ||
2-149569989-T-C | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Nov 22, 2021) | ||
2-149569996-A-C | Methylmalonic aciduria and homocystinuria type cblD | Uncertain significance (Sep 04, 2020) | ||
2-149570001-A-G | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Nov 05, 2023) | ||
2-149570008-T-G | Methylmalonic aciduria and homocystinuria type cblD | Uncertain significance (Aug 17, 2022) | ||
2-149570010-T-A | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Jan 28, 2024) | ||
2-149570019-A-G | Methylmalonic aciduria and homocystinuria type cblD | Benign (Feb 01, 2024) | ||
2-149570020-T-C | Inborn genetic diseases | Uncertain significance (Nov 27, 2023) | ||
2-149570025-G-A | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Mar 25, 2021) | ||
2-149570030-T-C | Methylmalonic aciduria and homocystinuria type cblD | Uncertain significance (Mar 29, 2022) | ||
2-149570037-T-C | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Dec 14, 2023) | ||
2-149570040-A-G | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Feb 25, 2023) | ||
2-149570043-T-C | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Jul 09, 2020) | ||
2-149570046-A-G | not specified • Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Nov 08, 2023) | ||
2-149570057-A-G | Methylmalonic aciduria and homocystinuria type cblD | Uncertain significance (Aug 24, 2021) | ||
2-149570065-T-C | Disorders of Intracellular Cobalamin Metabolism • Methylmalonic aciduria and homocystinuria type cblD | Uncertain significance (Jan 13, 2018) | ||
2-149570070-A-G | Methylmalonic aciduria and homocystinuria type cblD | Likely benign (Aug 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMADHC | protein_coding | protein_coding | ENST00000428879 | 7 | 18183 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000207 | 0.908 | 125716 | 0 | 24 | 125740 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.413 | 168 | 154 | 1.09 | 0.00000713 | 1934 |
Missense in Polyphen | 50 | 49.785 | 1.0043 | 600 | ||
Synonymous | -0.246 | 54 | 51.7 | 1.04 | 0.00000237 | 565 |
Loss of Function | 1.58 | 10 | 17.1 | 0.586 | 0.00000102 | 187 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000273 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.000273 | 0.000272 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in cobalamin metabolism (PubMed:18385497, PubMed:23415655, PubMed:24722857, PubMed:26364851). Plays a role in regulating the biosynthesis of two coenzymes, methylcobalamin and adenosylcobalamin (PubMed:18385497, PubMed:24722857). Plays a role in regulating the proportion of methylcobalamin and adenosylcobalamin (PubMed:23415655, PubMed:24722857). Promotes oxidation of cob(II)alamin bound to MMACHC (PubMed:26364851). {ECO:0000269|PubMed:18385497, ECO:0000269|PubMed:23415655, ECO:0000269|PubMed:24722857, ECO:0000269|PubMed:26364851}.;
- Pathway
- Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.313
- rvis_EVS
- 0.48
- rvis_percentile_EVS
- 79.25
Haploinsufficiency Scores
- pHI
- 0.174
- hipred
- N
- hipred_score
- 0.333
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.531
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mmadhc
- Phenotype
Gene ontology
- Biological process
- coenzyme biosynthetic process;cobalamin metabolic process
- Cellular component
- cytoplasm;mitochondrion;cytosol
- Molecular function
- protein binding